These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2760029

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM, Traish AM, Bambara RA, Hilf R.
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
    [Abstract] [Full Text] [Related]

  • 25. Chemical characterization by protein sequence analysis of the bovine estrogen receptor.
    Ratajczak T, Brockway MJ, Hähnel R, Moritz RL, Simpson RJ.
    Biochem Biophys Res Commun; 1988 Oct 14; 156(1):116-24. PubMed ID: 3178825
    [Abstract] [Full Text] [Related]

  • 26. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Hanson MB, Gallion H, Flanigan RC, Kenady DE.
    Biochemistry; 1985 Dec 31; 24(27):8101-6. PubMed ID: 4092059
    [Abstract] [Full Text] [Related]

  • 27. Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli.
    Seielstad DA, Carlson KE, Katzenellenbogen JA, Kushner PJ, Greene GL.
    Mol Endocrinol; 1995 Jun 31; 9(6):647-58. PubMed ID: 8592511
    [Abstract] [Full Text] [Related]

  • 28. Identification of cysteine 656 as the amino acid of hepatoma tissue culture cell glucocorticoid receptors that is covalently labeled by dexamethasone 21-mesylate.
    Simons SS, Pumphrey JG, Rudikoff S, Eisen HJ.
    J Biol Chem; 1987 Jul 15; 262(20):9676-80. PubMed ID: 3597435
    [Abstract] [Full Text] [Related]

  • 29. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 15; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 30. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Gallion H, Kenady DE.
    Endocrinology; 1987 Apr 15; 120(4):1608-14. PubMed ID: 3830064
    [Abstract] [Full Text] [Related]

  • 31. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
    Aliau S, Mattras H, Richard E, Borgna JL.
    Biochemistry; 1999 Nov 09; 38(45):14752-62. PubMed ID: 10555957
    [Abstract] [Full Text] [Related]

  • 32. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M, Greene G, Rochefort H, Jensen EV.
    Endocrinology; 1982 Apr 09; 110(4):1355-61. PubMed ID: 7060530
    [Abstract] [Full Text] [Related]

  • 33. Purification and characterization of nuclear type II [(3)H]estradiol binding sites from the rat uterus: covalent labeling with [(3)H]luteolin.
    Markaverich BM, Shoulars K, Brown MA.
    Steroids; 2001 Sep 09; 66(9):707-19. PubMed ID: 11546559
    [Abstract] [Full Text] [Related]

  • 34. Comparison of tritiated estradiol and tamoxifen aziridine for measurement of estrogen receptors in human breast cancer cytosols.
    Piccart MJ, Muquardt C, Bosman C, Pirotte P, Veenstra S, Grillo F, Leclercq G.
    J Natl Cancer Inst; 1991 Nov 06; 83(21):1553-9. PubMed ID: 1960752
    [Abstract] [Full Text] [Related]

  • 35. Proteolytic activity of the purified hormone-binding subunit in the estrogen receptor.
    Molinari AM, Abbondanza C, Armetta I, Medici N, Minucci S, Moncharmont B, Nigro V, Puca GA.
    Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4463-7. PubMed ID: 1709742
    [Abstract] [Full Text] [Related]

  • 36. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F, Rochefort H.
    Mol Cell Endocrinol; 1978 May 15; 11(2):181-98. PubMed ID: 680340
    [Abstract] [Full Text] [Related]

  • 37. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
    Reese JC, Katzenellenbogen BS.
    J Biol Chem; 1991 Jun 15; 266(17):10880-7. PubMed ID: 2040605
    [Abstract] [Full Text] [Related]

  • 38. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen.
    Sasson S, Notides AC.
    Mol Endocrinol; 1988 Apr 15; 2(4):307-12. PubMed ID: 3380103
    [Abstract] [Full Text] [Related]

  • 39. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A, Leclercq G.
    Biochem Biophys Res Commun; 1992 May 15; 184(3):1432-40. PubMed ID: 1590802
    [Abstract] [Full Text] [Related]

  • 40. An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity.
    Pakdel F, Le Goff P, Katzenellenbogen BS.
    J Steroid Biochem Mol Biol; 1993 Dec 15; 46(6):663-72. PubMed ID: 8274400
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.